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Abstract
Objectives Numerous approaches are used to estimate
indirect productivity losses using various wage estimates
applied to poor health in working aged adults. Considering
the different wage estimation approaches observed in the
published literature, we sought to assess variation in pro-
ductivity loss estimates when using average wages com-
pared with age-specific wages.
Methods Published estimates for average and age-specific
wages for combined male/female wages were obtained
from the UK Office of National Statistics. A polynomial
interpolation was used to convert 5-year age-banded wage
data into annual age-specific wages estimates. To compare
indirect cost estimates, average wages and age-specific
wages were used to project productivity losses at various
stages of life based on the human capital approach. Dis-
count rates of 0, 3, and 6 % were applied to projected age-
specific and average wage losses.
Results Using average wages was found to overestimate
lifetime wages in conditions afflicting those aged 1–27 and
57–67, while underestimating lifetime wages in those aged
27–57. The difference was most significant for children
where average wage overestimated wages by 15 % and for
40-year-olds where it underestimated wages by 14 %.
Conclusions Large differences in projecting productivity
losses exist when using the average wage applied over a
lifetime. Specifically, use of average wages overestimates
productivity losses between 8 and 15 % for childhood ill-
nesses. Furthermore, during prime working years, use of
average wages will underestimate productivity losses by
14 %. We suggest that to achieve more precise estimates of
productivity losses, age-specific wages should become the
standard analytic approach.
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Background
Assessing the broader consequences of disease is often
considered an important element of economic appraisals in
health. Health economic appraisals frequently take a wider
societal perspective, thus the quantification of productive
output or productivity losses (i.e., indirect costs resulting
from a disease) is fundamental to understanding the impact
of health outcomes. There are several methods which have
been used historically to quantify the loss of productive
output, including the human capital approach which has
been used very frequently in capturing indirect costs
associated with a disease. The human capital approach uses
gross wages as a proxy for productivity, although simply
applying labor wage rates is likely to underestimate
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societal losses, as workers actually generate more value
than purely reflected in their actual wages, as firms take
profits from productive output. In applying wages to esti-
mate productivity losses and a function of decreased pro-
ductivity (e.g., absenteeism, presenteeism), limited
guidance is available regarding the choice of wages to
include in the analysis. This explains the variation in how
indirect costs are often calculated, which ranges from using
average wages [1–5], GDP per capita [6–10], age-specific
wages [11–13], and in some cases not specifying how labor
was valued [14–16]. Choosing the most appropriate wage
data is especially important when considering the impact
that productivity costs can have on cost-effectiveness
thresholds.
In this methodological concept note, we compare two of
the more common implementation methods of the human
capital approach for calculating productive output loss;
namely, the use of average wages versus the use of age-
specific wages applied to morbidity and mortality events.
While average wages are often easier to identify in the
public domain, they do not reflect the established life cycle
of wages which is better reflected using age-specific wage
rates. The wage life cycle was established in human capital
economic theory since workers usually start their career
with low wages, see an increase as they gain more expe-
rience and expertise, and finally usually see a decrease in
wages as they often begin working less in old age, and their
employers are less incentivized to invest in older employ-
ees [17]. Due to the consistency and significance of the
variance of earnings over a lifetime, age-specific wages are
able to capture lifetime earnings projections more accu-
rately. We observe in the published literature that investi-
gators often arbitrarily use either average wage or age-
specific wages to estimate indirect costs without justifica-
tion for such choices. Our analysis attempts to demonstrate
how the use of each wage rate might influence the esti-
mation of lifetime productive output based on human
capital economics, and hence can be used as a tool to aid
analysts to better understand the degree to which age-
specific wage data is superior and how wages might need to
be adjusted to reflect the true lifetime productive output
which illnesses may influence.
Methods
To compare the difference in productivity losses we iden-
tified age-specific wage (2013–2014) data in 5-year incre-
ments over an individual’s working life, and average wages
for the United Kingdom [18]. Lifetime wage estimations
for an average individual were produced for a newborn
over his/her lifetime and subsequently the same estimation
was produced for different starting ages (e.g., a 45- or a
60-year-old permanently leaving the workforce). In the
present study, we sought to compare how use of average
wage rates with age-specific wage rates could influence
productivity loss estimates attributed to reduced work force
participation due to morbidity or mortality. For the nature
of this exercise, the specific illness to which productivity
losses would apply was not important, rather the incre-
mental indirect cost estimates that can occur at different
stages of life based on use of different wage rates attributed
to any health condition that can lead to productivity losses.
A polynomial interpolation was used to convert 5-year
wages data into annual age-specific wages estimates. A
discount rate of 3 % was applied to the projected age-
specific and average wage losses. A scenario analysis using
discount rates of 0 and 6 % were examined to estimate the
impact on the gap between age-specific and average wages.
Four metrics of productive output were generated for
comparison: undiscounted age-specific wages, discounted
age-specific wages, undiscounted average wages, and dis-
counted average wages. The average retirement age used
was 67 years for projected wage losses. In order to com-
pare the difference in accuracy between average and age-
specific wage data at different stages of life, the percentage
by which average wage varies from average lifetime wages
by age group was calculated. This provided insight into
whether average wages data overestimated or underesti-
mated lifetime productive output for different age groups.
Results
Figure 1 illustrates the average wage and age-specific
indirect cost calculations for an illness that may affect a
newborn child in the UK over their projected lifetime. In
the base analysis costs were discounted at 3 %. Figure 2
depicts the corresponding percentage difference in the
estimated lifetime productive output for different starting
ages of a health condition. From age 1–25 and 57–67, using
average wage will likely overestimate lifetime productive
output. Likewise, using average wages for those between
25 and 56 years of age will underestimate lifetime pro-
ductive output. The difference in lifetime wages estimation
can be thought of as a margin of error incurred by using
average wage data to estimate lost potential earnings: if
one was to estimate lifetime wage losses of a 25- or
57-year-old, the margin of error would be near zero. Using
average wage to estimate lifetime earning potential of a
child or a 40-year-old, however, could lead to an overes-
timation of 15.24 % or an underestimation of 14.3 %,
respectively. Figure 3 depicts the incremental between
curves calculated using different discount rates. The higher
the discount rate used, the higher the margin of error for
estimating the future potential earnings of a young adult or
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child. For example, for a childhood health condition with
permanent disability at 0 % discount rate the average wage
overestimates indirect costs by 5.5 %. When 3 and 6 %
discount rates are applied using average wages, indirect
costs are overestimated by 13.5 and 23.3 %, respectively.
The data in Fig. 3 is for illustrative purposes and will vary
depending on the age of illness onset and discount rate as
depicted in the graph. However, over time, the discount
rate used has less of an impact on the incremental differ-
ence between average wage and age-specific wages, with
the curves converging in older workers, i.e., those over
58 years of age.
Discussion
The analysis described here illustrates the disadvantages
associated with using average wages to reflect lifetime
productivity losses, and thus indirect costs, using the
human capital approach. Whilst average wage data offers
analytic simplicity, and is easier to identify for many
countries, it does not adequately reflect indirect produc-
tivity losses attributed to morbidity and mortality. In fact,
our analysis indicates that the use of average wages either
overestimates or underestimates lost productive output
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Fig. 1 Illustration of
discounted and undiscounted
productivity loss estimates
obtained in a 1-year-old child


































Fig. 2 Difference in lifetime
earnings estimation (LEE) age-
specific/average wage
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impact occurs. Age-specific wages reflect many key ele-
ments of the labor market over a lifetime, including the
accumulation of knowledge, changes in productivity, and
specialization of skills, allowing variation in ability to
barter wages. Failing to consider these shifts in wages over
a life cycle can lead to significant inaccuracies in esti-
mating indirect costs of morbidity and mortality.
One could argue that the differences described here may
be inconsequential in many analyses, particularly consider-
ing that only a limited number of countries take into con-
sideration productivity loss or indirect costs in
reimbursement decisions that influence formulary access.
However, previous studies [2] have shown that the inclusion
of indirect costs can influence the likelihood that a product
may be cost-effective or not. In some cases, this simple
methodological adjustment could even change the viability
of policy choices by altering their projected impact. Bearing
in mind that the inclusion of indirect costs may change
conclusions on cost-effectiveness underlines the importance
of adequately calculating these costs. The findings described
here would also be relevant for investigators applying the
friction cost approach. The message described here is
focused on the choice of wages, and not about the time
estimates attributed to lost work from disease.
Since the introduction of labor wage rates to decision
making, analysts have sought to understand the broader
consequences of health. Few would dispute that labor wage
rates are a poor proxy for value because they do not
account for other forms of economic contribution an indi-
vidual can bring to society; however, they can be imple-
mented to grasp a more complete understanding of the
indirect costs of illness, thereby increasing the accuracy of
the value of treatment. To ensure the highest possible
degree of accuracy when estimating indirect costs using
these methods, the metric used to measure wage is key.
Age-specific wages should be used in most circumstances
whenever available; if not, the resulting imprecision of
using average wages data must be taken into account. In
the absence of age-specific data, the relationship between
age-specific wages and average wages described here may
offer a factor adjustment that allows for improved
precision.
The life cycle of wages reflected by age-specific wages
is well established in published literature [19]. The con-
sistency of this relationship suggests that the results
described here are applicable to other countries, high-
lighting the importance of using age-specific wages more
broadly. Although the exact degree to which average wage
data misestimates lifetime earnings will vary across coun-
tries, the general curve of earnings over a lifetime is con-
sistent across similar countries. This knowledge should be
considered when choosing a metric to project potential
income or calculate the present value of lost lifetime
earnings as an indirect societal cost of death by illness.
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